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Abstract
Background: Obesity-related diseases are major contributors to morbidity and mortality in the developed world.
Molecular diagnostics and targets of therapies to combat nutritional imbalance are urgently needed in the clinic.
Invertebrate animals have been a cornerstone of basic research efforts to dissect the genetics of metabolism and
nutrient response. We set out to use fruit flies reared on restricted and nutrient-rich diets to identify genes
associated with starvation resistance, body mass and composition, in a survey of genetic variation across the
Drosophila Genetic Reference Panel (DGRP).
Results: We measured starvation resistance, body weight and composition in DGRP lines on each of two diets and
used several association mapping strategies to harness this panel of phenotypes for molecular insights. We tested
DNA sequence variants for a relationship with single metabolic traits and with multiple traits at once, using a
scheme for cross-phenotype association mapping; we focused our association tests on homologs of human disease
genes and common polymorphisms; and we tested for gene-by-diet interactions. The results revealed gene and
gene-by-diet associations between 17 variants and body mass, whole-body triglyceride and glucose content, or
starvation resistance. Focused molecular experiments validated the role in body mass of an uncharacterized gene,
CG43921 (which we rename heavyweight), and previously unknown functions for the diacylglycerol kinase rdgA, the
huntingtin homolog htt, and the ceramide synthase schlank in nutrient-dependent body mass, starvation resistance,
and lifespan.
Conclusions: Our findings implicate a wealth of gene candidates in fly metabolism and nutrient response, and
ascribe novel functions to htt, rdgA, hwt and schlank.
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Background
Obesity is a worldwide epidemic and among the leading
causes of morbidity and mortality in the US, increasing
susceptibility to chronic pathologies that impact many
body systems [1]. Against a backdrop of landmark ad-
vances in dissections of the basic biology of metabolism
[2], geneticists continue to search for novel genes that
modulate body composition and diet responses, as po-
tential targets for drug development. Such factors have
emerged from mapping studies in human populations
[3] and in mice reared on a high-fat diet [4–6], though
only a handful have been validated at the single-gene
level [3]. As a complement to mammals, invertebrate
model organisms offer a far quicker route to the discov-
ery and validation of nutrient response genes. In the
fruit fly, classic mutagenesis screens have enabled land-
mark discoveries of obesity and body composition genes
conserved in vertebrates [7–12]. These screens have
been applied to one qualitative, easily-scored trait at a
time. Consequently, geneticists have had an incomplete
understanding of how multiple aspects of metabolism
are coordinated in response to the organism’s changing
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needs, even for the well-studied insulin [13, 14] and tar-
get of rapamycin (TOR) [15] pathways in the fly and
other model organisms.
The advent of the Drosophila Genetic Reference Panel
(DGRP) enables the mapping of natural phenotypic
variation to DNA sequence in flies with an association
paradigm [16, 17]. Genome-wide association studies
(GWAS), by using populations in which many natural
genetic variants are segregating at once, can require or-
ders of magnitude less phenotyping effort than system-
atic screens perturbing each gene in turn. As such,
GWAS makes possible the genetic dissection of traits
that require assays too nuanced or time-consuming for
mutagenesis studies, including many aspects of metabol-
ism and dietary response. And alongside its use in gene
discovery, GWAS also reveals the genetic architecture of
natural variation in a trait of interest. These strengths
have motivated previous studies focused on metabolic
rate and body size and composition in the fly, yielding a
number of intriguing candidate genes and polymor-
phisms [16, 18–22].
A potential strategy to boost power in GWAS is the
use of cross-phenotype association tests, to search for
cases in which a genetic variant associates with multiple
traits at once [23]. The recent success of principal
component-based methods for this purpose in the fly
[24] has led to a first set of candidate cases in which
master regulatory loci associate jointly with multiple
facets of metabolism. We reasoned that any such candi-
date would serve as a high-value candidate for experi-
mental validation. We also expected that association
tests for gene-by-diet interactions, which have not as yet
been implemented in the fly [19, 21, 25, 26], could be
harnessed to reveal novel genetic determinants of me-
tabolism. We thus set out to use cross-phenotype associ-
ation tests in the DGRP, along with single-phenotype
GWAS approaches, to generate testable hypotheses
about genes underlying metabolic traits and the response
to changing diet.
Results
We surveyed natural genetic variation across genetically
distinct fly lines in metabolic behaviors and their de-
pendence on dietary yeast restriction. Dietary yeast levels
are known to modulate fly body composition, stress re-
sistance, and lifespan in laboratory strains [27–30]. We
reared 171–181 DGRP lines on two diets (ad libitum,
AL, 5 % yeast; dietary restriction, DR, 0.5 % yeast), using
non-virgin females to avoid effects of mating status on
diet–responsive phenotypes [31]. In each, we measured
wet body mass, resistance to acute starvation, and
whole-body triglyceride and glucose levels (Additional
file 1: Figure S1). As expected [32–36], on average DR
treatment was associated with an increase in all traits
except wet body mass, which decreased in DR flies rela-
tive to AL flies (Additional file 1: Figure S1). Phenotype
values of a given strain reared on the two diets were
correlated (R2 = 0.53-0.69; Additional file 1: Table S1),
indicating a sizeable genetic contribution to phenotype,
independent of diet. Indeed, heritabilities ranged from
modest to high for the GWAS phenotypes (47–93 %;
Additional file 1: Table S2). For most traits, the ratio of
the respective values measured in flies reared on the AL
and DR diets was also highly heritable (Additional file 1:
Table S2).
GWAS of metabolic traits
To begin to identify the genetic basis of variation across
DGRP lines in metabolic behaviors, we tested each trait
in turn for association to each of the 1.9 million variants
segregating in the population with minor allele fre-
quency ≥5 %. Our association paradigm used a linear re-
gression method that included terms in the model for
the effect of genotype at a given locus, its interaction
with diet, and diet itself, and we corrected for multiple
testing via permutation. At an experiment-wise thresh-
old for significance corresponding to false discovery
rate ≤ 10 %, we mapped diet-independent effects of one
polymorphic locus, nimb3, to measurements of resist-
ance of acute starvation, and another locus, 14-3-3 epsi-
lon, to whole-body triglyceride content (Table 1). The
top-scoring polymorphisms in these genes explained
18–20 % of the genotypic variance in their respective
phenotypes (Table 1). Together, these association results
provided a first line of evidence that our GWAS could
identify genes that govern variation in fly metabolism.
We used the results from each genome-wide scan as
input into tests of groups of genes of common function
for enriched association signal, using GOglm [37]. Emer-
ging from this analysis were eight GO terms whose
genes tended to associate with different aspects of me-
tabolism (Additional file 1: Table S3). Most notable was
the enrichment of association signal, for body mass and
glucose levels, in sensory perception and antennal mor-
phogenesis genes, suggesting the possibility that some
variants modulating these traits act by tuning animals’
perception of food [38–40].
Cross-phenotype association mapping
We reasoned that a complementary strategy to mine our
panel of metabolic trait measurements in DGRP lines
would be to test a given variant for association with
multiple traits at once. For this purpose, we used each
pair of phenotypes in turn (from among our set of four
phenotypes in animals reared on each diet; Additional
file 1: Figure S1) as input into the multiple-phenotype
association test (SMAT; [41]). Genome-wide scans with
this paradigm were not sufficiently well-powered to map
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loci at reasonable false discovery rates after permutation-
based multiple testing correction (see Methods and
Additional file 1: Table S4). To improve power, and
motivated by the clinical interest in human diseases
where nutrition is a risk factor, we developed a test
pipeline specialized to fly homologs of a broad range of
human disease genes (as curated by Online Mendelian In-
heritance in Man [42]; see Methods). Our rationale was
that any genes of this set, if mapped in our associ-
ation calculations, would likely be only a subset of
the full complement of loci causal for the respective
trait, but would be of particular interest as candidates
for translational applications. Scans of human disease
loci using SMAT attained power in a number of trait
pairs, when considered independently (Additional file
1: Table S4) and when corrected for multiple testing
across pairs (see Methods). Emerging from the results
was strong signal for six polymorphisms jointly asso-
ciating with starvation resistance and body mass, in
DR flies and, separately, in flies reared on the AL diet
(Table 1). These polymorphisms were in eIF4G2, a
paralog of the nutrient-sensing factor eIF4G [43]; the
ceramide synthase gene schlank; and the Drosophila
homolog of huntingtin, the gene underlying human
Huntington’s disease (Table 1). These associations ex-
plained 8–12 % of the genetic variance in starvation
resistance or body mass (Table 1). Cross-phenotype map-
ping also found associations between starvation resistance
and triglyceride levels and two loci (Table 1): CG7560,
an FAD-linked oxidoreductase involved in methionine
metabolism [44], and Cht12, a chitinase involved in cu-
ticle formation [45]. Tests for gene sets with enriched
association signal in cross-phenotype tests revealed as-
sociation between starvation resistance and glucose
content and genes annotated in ventral cord develop-
ment (Additional file 1: Table S3), raising the possibility
that these characters could be affected by variants that
act in the central nervous system, plausibly via loco-
motor hyperactivity during starvation [38–40]. These
data established our cross-phenotype association tests
as a useful tool in the mapping of genotype to pheno-
type for metabolic traits.
Table 1 Variants associated with metabolic traits
Screena Phenotype(s)b Testb Chrc Positionc Genec % Vard pe FDRf
MAF ≥ 5 % starvation resistance genotype 2L 13967604 nimB3 18 % 3.70E-13 0 %
MAF ≥ 5 % triglycerides genotype 3R 14072066 14-3-3 ε 20 % 1.29E-14 10 %
MAF ≥ 5 % starvation resistance and triglycerides on AL SMAT 3L 11418293 CG7560 8 % 8.88E-16 0 %
MAF ≥ 5 % starvation resistance and triglycerides on AL SMAT 2R 16952034 Cht12 6 % 6.18E-11 10 %
MAF ≥ 5 % starvation resistance and mass on AL SMAT 3R 19635620 EIF4G2 8 % 1.71E-13 10 %
MAF ≥ 5 % starvation resistance and mass on AL SMAT 3R 24549344 htt 12 % 2.78E-12 10 %
MAF ≥ 5 % starvation resistance and mass on DR SMAT X 6152605 schlank 3 % 4.44E-16 0 %
MAF ≥ 5 % starvation resistance and mass on DR SMAT X 6152619 schlank 3 % 4.44E-16 0 %
MAF ≥ 5 % starvation resistance and mass on DR SMAT X 6152558 schlank 2 % 6.66E-16 0 %
MAF ≥ 5 % starvation resistance and mass on DR SMAT X 6152586 schlank 2 % 8.88E-16 0 %
MAF ≥ 25 % body mass genotype X 12430723 CG43921 15 % 3.84E-13 0 %
MAF ≥ 25 % glucose interaction 3R 8877613 pic 4 % 5.94E-3 7 %
MAF ≥ 25 % glucose interaction 3R 8877592 pic 4 % 6.72E-3 7 %
MAF ≥ 25 % glucose interaction 3R 8877227 CG7966 5 % 6.75E-3 7 %
MAF ≥ 25 % glucose interaction 3R 8877378 CG7966 5 % 8.69E-3 8 %
MAF ≥ 25 % starvation genotype 2L 13967604 nimB3 18 % 3.70E-13 0 %
MAF ≥ 25 % starvation resistance and mass on DR SMAT X 8903670 rdgA 15 % 1.27E-08 10 %
MAF ≥ 25 % starvation resistance and triglycerides on DR SMAT 3R 4279209 CG43462 8 % 1.29E-09 10 %
aResults from association scans across markers meeting the indicated criterion. For results from the scaled multiple-phenotype association test (SMAT) applied to
variants at frequency of ≥5 %, only human disease orthologs were tested
bThe single phenotype whose measurements in animals reared on both diets were tested in a linear model with terms for diet, genotype, and the interaction
between the two; or the pair of phenotypes whose measurements in animals reared on the indicated diet were tested via SMAT. DR, dietary restriction; AL,
ad libitum
cChromosome segment, position (in D. melanogaster genome version R5 coordinates), and gene in which the associating marker lay
dPercent phenotypic variation explained by the indicated polymorphism. For pairs of phenotypes, the value reports results for the single phenotype with the
highest % variance explained
eNominal association p-value
fFalse discovery rate at the association p-value according to permutation analysis
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A new role for schlank in nutrient response and lifespan
in adult flies
Among our cross-phenotype association hits, as a first
test of functional validation we focused on schlank, given
its known role as a determinant of lipid accumulation in
fly larvae [46] and, in yeast, as a determinant of lifespan
[47]. The association between intronic variants in schlank
and starvation resistance and body mass reached
experiment-wide significance in DR flies (Table 1) and was
also apparent in flies on the AL diet (Fig. 1a-b). Since loss
of schlank function compromises viability beyond the
larval stage [46], to investigate its role in metabolic traits
during adulthood we crossed a stock ubiquitously express-
ing the GeneSwitch (GS) regulator, which is inducible upon
treatment with RU486 [48], to a TRiP background stock
[49] harboring a GAL4-controlled schlank RNAi transgene.
In the progeny, upon induction we confirmed schlank
knockdown by qRT-PCR (Additional file 1: Figure S2). We
first focused on acute starvation resistance, which increases
in wild-type flies reared under chronic nutrient deprivation
in a manner dependent on changes in fat metabolism [36].
Strikingly, schlank knockdown during adulthood com-
pletely abrogated this advantage of the DR treatment: star-
vation resistance in knockdown flies reared on DR was
59 % of wild-type controls, on par with that of animals
reared under AL (Fig. 1c). Further testing revealed a diet-
independent, 5–13 % reduction in body mass in schlank
knockdown flies (Fig. 1d), and also a loss of 10 % in trigly-
ceride content (Fig. 1e). Negative controls ruled out effects
on these traits from RU486 treatment alone (Additional file
1: Figures S3 and S4). These data make clear that schlank
is of critical importance for the enhanced starvation resist-
ance among DR flies, likely via remodeling of fat storage
and catabolism in flies reared on this diet [36]. Lifespan as-
says suggested a potential role for schlank in DR-induced
longevity, as knockdown of this gene shortened lifespan to
a slightly greater degree in flies reared on the restricted diet




Fig. 1 The ceramide synthase schlank governs body mass, starvation, and lifespan. a and b Trait association to schlank genotype in the DGRP. In
a given panel, each point reports phenotype measurements (y-axis) from one DGRP strain homozygous for the schlank allele indicated on the
x-axis. Each black horizontal bar reports the mean phenotype across all strains harboring the indicated allele. c-e Validation of schlank function. c
Each trace reports survival of a strain harboring a schlank RNAi construct and a GAL4-GeneSwitch (GS) activator under the daughterless
promoter, pre-treated with RU486 (+ drug, dotted lines) or vehicle (no drug, solid lines) for 10 days on the indicated diet and then switched to
acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes as in c (n = 2 populations of 15 flies per
condition). e Each column reports whole body triglyceride levels per fly of the indicated strain, with genotypes as in c (n = 1 population of 15 flies
per condition). For d and e top, middle, and bottom horizontal bars of a given vertical box denote the respective quartiles over batches and/or
technical replicates, and the top and bottom short horizontal bars report minimum and maximum, respectively. AL, ad libitum diet; DR, dietary
restriction. *, p < 0.05, **, p < 0.01, ***, p < 10-3, ****, p <10-7, *****, p < 10-15. Red asterisks denote significance of the effect of the genetic perturbation
in animals on AL food, blue denotes significance in animals on DR food, and purple denotes significance of the interaction between diet and genetic
perturbation. For strain details see Additional file 1: Table S6
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Together, our discoveries of a role for schlank in nutrient-
dependent changes in starvation resistance, as well as body
weight, provide a first compelling validation of multi-
phenotype association signal in the DGRP as a signpost for
genes with true metabolic function.
A metabolic role for fly htt
As a second case study for functional confirmation of
our cross-phenotype mapping results, we focused on htt,
the Drosophila huntingtin gene. In our survey of DGRP
lines, a single-base insertion in an intron of fly htt
reached significance for joint association to body mass
and starvation resistance, in animals on the AL diet
(Table 1), and a similar effect was discernable upon
manual inspection in DR flies (Fig. 2a-b). A metabolic
role for fly htt would be consistent with the symptoms
of human Huntington’s patients, who, even on pre-
scribed diets of thousands of excess calories a day, often
fail to maintain body mass [50, 51]. To verify the de-
pendence of fly nutrient responsive traits on htt, we bred
a line with constitutive, ubiquitous expression of an htt
RNAi construct, and confirmed knockdown in this strain
by qRT-PCR (Additional file 1: Figure S2). This htt
knockdown line exhibited marked improvements in star-
vation resistance relative to isogenic controls, in DR flies
and, to a lesser degree, in animals reared on the AL diet
(Fig. 2c). Knockdown of htt also conferred robust in-
creases in body mass, with a slightly stronger effect in
animals on AL food than on DR (24 versus 22 %, re-
spectively; Fig. 2d), but had no significant effect on tri-
glyceride content (Additional file 1: Figure S4). To test
htt’s role in longevity while avoiding the potential for
knockdown effects during development, we bred flies ex-
pressing drug-inducible, ubiquitous htt RNAi, and in-
duced the transgene only after eclosion, confirming
knockdown by qRT-PCR (Additional file 1: Figure S2).
The resulting htt knockdown in adult animals conferred
a 9 % lifespan extension on the AL diet and decreased
lifespan in DR animals by 5 % relative to isogenic con-
trols, effects that could not be attributed to inducer
treatment alone (Additional file 1: Figure S5). These data
make clear that reduced htt expression can alter longev-
ity and promote starvation resistance and increase body
mass, likely through mechanisms that do not involve
changes to steady-state triglyceride levels. As nutrient
restriction enhanced some of these effects, mitigated
others, and had no detectable effect on the natural vari-
ant originally emerging in our association scan, htt likely




Fig. 2 A metabolic function for fly huntingtin (htt). a and b Trait association to htt genotype in the DGRP. Data are as in Fig. 1a-b, except that an
intronic indel in htt is analyzed. c and d Validation of htt function in laboratory strains. c Each trace reports survival of a strain expressing a GAL4
activator under the daughterless promoter and harboring an htt RNAi construct (RNAi) or no RNAi transgene (control), pre-treated for 10 days on
the indicated diet and then switched to acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes
as in c. (n = 5 populations of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see Additional file 1: Table S6
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Common variants associated with metabolic traits
As an additional strategy to improve mapping power in
the DGRP, we developed a scheme for analysis of poly-
morphisms at which the minor allele was very common.
We expected that common variants mapped to a given
trait might only represent a fraction of its full genetic
architecture, but we considered this restriction a justifi-
able trade-off in light of the expected high power in as-
sociation tests of common variants where the number of
observations among individuals bearing the minor allele
is maximized. For a first evaluation of this strategy, we
applied our linear model association test framework for
a given trait, including genotype and gene-by-diet inter-
action effects, to the 734,670 markers in the DGRP with
minor allele frequency ≥25 %. This genome-scale scan
uncovered significant, diet-independent association be-
tween genotype at nimb3 and acute starvation resistance,
as we had observed in scans of variants at lower allele
frequencies; we also detected association to body mass
at the uncharacterized gene CG43921 (Table 1). Gene-
by-diet association was significant between whole-body
glucose measurements and a locus encompassing the
cleavage and polyadenylation factor pic and the unchar-
acterized gene CG7966 (Table 1). These loci explained
up to 18 % of the variance in their respective traits
(Table 1). Functional genomic tests revealed enrichment
in association to starvation resistance among genes
categories annotated in actin filament production
(Additional file 1: Table S5). In the latter, top-scoring genes
were Arp2, Arpc2, and SCAR (association p = 0.0008, 0.001,
and 0.003 respectively), which have roles in the devel-
opment of neural processes and axonal defasciculation
[52, 53]. Also emerging from functional genomic tests
was an enrichment in association to starvation resist-
ance among heterophilic cell-cell adhesion genes
(Additional file 1: Table S5); these included Notch (as-
sociation p = 0.006), among whose many biological
roles is that of axon guidance [54], and “beaten path”
genes such as beat-Ib, beat-IIIb, and beat-Va (associ-
ation p = 0.00001, p = 0.00008, p = 0.0002 respectively),
which are involved in motor neuron defasciculation
[55]. These results suggest that variants acting to tune
development of the nervous system, if they modulate
feeding or physical activity, could have downstream
influences on metabolism [56].
CG43921/heavyweight is a novel determinant of body mass
For a validation of a top-scoring locus from our associ-
ation tests of common variants, we focused on the
uncharacterized gene CG43921, in which an intronic
polymorphism associated with body mass across DGRP
lines in a diet-independent manner (Table 1 and Fig. 3a).
To verify the dependence of fly body mass on CG43921,
we bred a line with constitutive expression of a CG43921
RNAi construct under a ubiquitous, constitutive driver,
and we confirmed knockdown in this strain by qRT-PCR
(Additional file 1: Figure S2). Knockdown of CG43921 by
this strategy increased body mass by 9 % relative to
isogenic controls in flies reared on the AL diet, with no
significant effect in DR animals (Fig. 3b). We did not find
significant changes in triglyceride levels (Additional file 1:
Figure S4) or lifespan (Additional file 1: Figure S5) and we
observed only minor extension of starvation resistance
(Additional file 1: Figure S6) in CG43921 knockdown
flies. These data implicate CG43921 primarily in the
control of body mass, the trait that showed the strongest
association signal, and as such we give this gene the com-
mon name heavyweight (hwt).
Diet-dependent metabolic function of rdgA
Paralleling our analyses of low-frequency variants, we
used the set of common variants in the DGRP as input
into tests for cross-phenotype associations, analyzing
each pair of our phenotypes on each diet. Two signifi-
cant single-locus mapping results emerged from analysis
of flies reared on DR. Genotype at CG43462, a suspected
determinant of fly lifespan [57], was associated with star-
vation resistance and triglyceride levels; the diacylglyc-
erol kinase gene rdgA (Table 1), whose mammalian
homologs have been implicated in diabetes and obesity
risk [58, 59] and which also modulates fly lifespan [60],
associated with body mass and starvation resistance.
Functional genomic tests detected enriched association,
in our joint analysis of starvation resistance and body
mass, in two sets of genes annotated in alcohol catabol-
ism (Additional file 1: Table S5). Top-scoring genes in
these categories were three sphingomyelin phosphodies-
terases (CG15533, CG15534, and CG3376; association
p = 0.0099, 0.0012, and 0.0013, respectively) and two
phosphatidylinositol phosphatases (Plip and Pten, associ-
ation p = 0.0022 and 0.0056, respectively), highlighting the
potential for variants throughout phospholipid pathways
that could perturb metabolism in the DGRP.
We chose rdgA for an additional validation case study,
on the strength of previous evidence that it interacts
with the TOR pathway and modulates lifespan [60]. The
natural variant segregating in the DGRP in rdgA was as-
sociated with stronger effects in animals reared on the
DR diet than on AL (Fig. 4a and b), though this diet de-
pendence did not reach significance in our starvation re-
sistance GWAS. We reasoned that disruption of rdgA
might affect metabolic characters in a diet-specific
manner. To test this, we first phenotyped flies bearing a
transposon insertion in rdgA [61]. Relative to background-
matched controls, these mutants survived acute starvation
for 51 % longer after rearing on the DR diet, with a more
modest 16 % increase after pre-treatment on the AL diet
(Fig. 4c). rdgA mutants also exhibited an increase in mass,
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with an effect significantly stronger in DR flies than those
on AL food (24 and 3 %, respectively; Fig. 4d). Consistent
with the gain in body mass on DR, there was a significant
12 % increase in triglyceride levels in rdgA mutant flies
relative to controls on DR but not AL (Fig. 4e). To investi-
gate the role of rdgA in lifespan, we used a drug-inducible
RNAi construct, triggering knockdown only in adulthood.
Mirroring results of a previous study in flies reared on a
single diet [60], we found that neuron-specific knockdown
of rdgA was sufficient for lifespan extension; however, our
data revealed this effect to be most pronounced during
DR (9 % extension), and almost undetectable on the AL
diet (Additional file 1: Figure S5). We conclude that
laboratory-induced perturbations to rdgA impact starva-
tion resistance, body mass, and lifespan. The striking diet
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Fig. 3 CG43921/heavyweight is a novel determinant of body mass. a DGRP trait association with heavyweight (hwt) genotype. Data are as in
Fig. 1a-b except that an intronic variant in hwt is analyzed. b Validation of hwt function in laboratory strains. Each column reports body mass per
fly of a strain expressing a GAL4 activator under the daughterless promoter and harboring an hwt RNAi construct (RNAi) or no RNAi transgene
(control) (n = 2 populations of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see Additional file 1: Table S6





























































































































































Fig. 4 The diacylglycerol kinase rdgA governs body mass, starvation resistance, and lifespan. a and b Trait association to rdgA genotype in the
DGRP. Data are as in Fig. 1a-b, except that an intronic variant in rdgA is analyzed. c-e Validation of rdgA function in laboratory strains. c Each
trace reports survival of a strain harboring a transposon insertion in rdgA (mutant) or isogenic wild-type control, pre-treated for 10 days on the
indicated diet and then switched to acute starvation media. d Each column reports body mass per fly of the indicated strain, with genotypes as
in c (n = 2 populations of 15 flies per condition). e Each column reports whole body triglyceride levels normalized to body mass in the
indicated strain, with genotypes as in c (n = 1 population of 15 flies per condition). Symbols and abbreviations are as in Fig. 1. For strain details see
Additional file 1: Table S6
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polymorphisms at the locus, reflect a likely role for rdgA
in nutrient response, as expected given its interactions
with TOR signaling [60].
Discussion
A direct consequence of obesity is the increased prob-
ability of age-related pathologies, including diabetes, car-
diovascular disease, neurodegenerative disorders and
cancer [1]. Conversely, fasting and dietary restriction
prolong lifespan and delay the onset of chronic diseases
[29, 62, 63]. The genes that underlie these effects are
prime targets for pro-healthspan drugs and personalized
diets, and natural variation mapping strategies are well
suited for expedient screens to discover these factors. In
this work, we have implemented several strategies for
highly-powered GWAS in the fly, including a focus on
homologs of genes involved in human disease and com-
mon variants, and tests of a given variant for joint rela-
tionships to multiple traits in parallel. Our work also
provides a first window onto gene-by-diet interactions in
the DGRP. In total, our association scans of common al-
leles and disease gene homologs have implicated 17 vari-
ants, in 12 genes, in nutrient response traits. And we
identified groups of genes of common function with
enriched association to metabolic traits, although formally,
nuanced statistical biases would need to be ruled out as
the potential source for any such pathway signal [64].
Among the single-locus GWAS hits validated in our
study, three have confirmed or hypothesized roles in
phospholipid signaling and lipid metabolism. rdgA en-
codes a diacylglycerol kinase that catalyzes the formation
of phosphatidic acid, a phospholipid with pleiotropic sig-
naling effects [60, 65]. Our discovery of rdgA as a regula-
tor of body mass, starvation resistance, and lifespan
dovetails with the remarkable pleiotropy of this gene, in-
cluding roles in taste [66] and smell [67] as well as
phototransduction [68], sound [69], temperature percep-
tion [70], and lifespan [60]. Under one plausible model,
rdgA’s main link to body mass and nutrient response
could be in the control of taste preference and/or feed-
ing behavior. Alternatively, rdgA’s metabolic role could
involve its known link to TOR signaling [60, 65, 71],
plausibly via regulation of macroautophagy in the fat
body [72] or global regulation of translation in response
to stress [73]. The latter would be consistent with our
finding that rdgA mutants are only long-lived when on a
restricted diet. Another of our validated GWAS hit loci,
the ceramide synthase schlank (homologous to the yeast
lifespan gene LAG1 [47]), is known to control larval
body size and fat accumulation [46]. Compromised lipid
storage is therefore a potential proximal cause for the
drop in body mass, starvation resistance, and lifespan we
observe upon schlank knockdown in adult flies. The lat-
ter effects could involve the redirection of biosynthetic
resources to other lipid pathways as ceramide and
sphingolipid biosynthesis is blocked, since schlank loss
of function is known to perturb levels of a number of
lipid species [46]. However, it is tempting to speculate
that schlank could act as a master metabolic regulator, in
light of its ubiquitous expression and the evidence for cer-
amide as a mediator of apoptosis [74, 75] and MAPKKK/
JNK mediated stress-response signaling [74, 76, 77] in the
fly. A third gene on which we focus here, CG43921 (which
we have named heavyweight), is of unknown biochemical
function but is annotated with a FYVE domain which may
bind phosphatidylinositol 3-phosphate (PI3P) [78], as well
as a src homology 2 domain [79]. Future work will be ne-
cessary to establish whether rdgA, schlank, and hwt, and
the cohort of additional phospholipid metabolic genes in
which we detected enriched association signal (Additional
file 1: Table S5), indeed exert effects on body mass and
starvation resistance via phospholipid signaling. A particu-
larly compelling model would invoke phospholipid regula-
tion of the insulin pathway, to modulate apoptosis and
cell growth [80] and/or glucose homeostasis [81–84].
Our results also reveal a novel metabolic function for
fly huntingtin, reminiscent of the weight loss seen in hu-
man Huntington’s patients [50, 51] and in some mouse
models of the disease [85–88]. The molecular-genetic
origin of these phenotypes is a subject of ongoing de-
bate, since in principle it could manifest from either a
toxic gain-of-function in the mutant protein or a loss of
wildtype huntingtin function [51, 86, 89]. As we ob-
served dramatic increases in body size and starvation re-
sistance in htt knockdown flies, our study provides a
first compelling rationale for refuting the hypothesis that
weight loss results from huntingtin loss of function. Our
data leaves open the question of how native htt acts as a
negative regulator of body mass and starvation resist-
ance. Conceivably, its metabolic function could be medi-
ated by circulating leptin and adiponectin [85, 89] and/
or IGF-1 [89], which are perturbed by Huntington’s
disease mutations in mammals. In the face of the early
lethality of mouse huntingtin nulls [90] and the develop-
mental defects in huntingtin knockdown zebrafish [91],
expedient invertebrate models are sorely needed in the
field. Our analyses of fly htt lay the groundwork for tests
of mechanistic hypotheses centered around this key
human disease gene.
Conclusions
We have conducted genome-wide scans for variants as-
sociated with starvation resistance, body mass and com-
position and their response to changing diets. We have
validated the effects of schlank, rdgA, and htt on diet-
dependent traits, and we have uncovered a panel of
additional candidates for future analyses. Alongside
these novel genetic discoveries, our experimental design
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sets a precedent for the use of gene-by-diet and cross-
phenotype association tests in fruit fly GWAS.
Methods
DGRP phenotyping
DGRP lines were obtained from the Bloomington
Drosophila Stock Center [92]. Fly husbandry and food
were as previously described [36].
To measure starvation resistance for a given line, an
isogenic population of 100 non-virgin female flies was
reared on either DR (0.5 % yeast) or AL (5 % yeast) food
from the day of eclosion, with 25 flies per vial. After
10 days, flies were switched to starvation media (agar
providing water but containing no nutrients), and deaths
of flies were counted three times daily until all flies died;
we then tabulated the average time to death across this
isogenic population for use in statistical genetics ana-
lyses below. One biological replicate (one batch of 100
animals) was assayed for 159 DGRP strains and two bio-
logical replicates (two batches of 100 animals assayed
starting on two different days) for another 12 strains.
For body mass, glucose and triglyceride measurements
for a given line, an isogenic population of 15 seven day
old non-virgin female flies was weighed in groups of 3
flies and then homogenized in 200 μl PBS and frozen. In
contrast to the constitutive RNAi experiments, for adult-
induced schlank RNAi we sampled schlank flies at
14 days after eclosion to allow enough time to observe a
change in body weight and body composition. This
whole-fly homogenate was subjected to two technical
replicates of both the StanBio Triglycerides LiquiColor®
Test (Cat# 2100-225) and the Glucose Liqui-UV® Test
(Cat# 1060-500). The measurements were normalized to
body mass [36]. One biological replicate (one batch of
15 animals) was assayed for 88 DGRP strains and two
biological replicates (two batches of 15 animals each
assayed on each of 2 days) for another 93 strains.
We filtered out cases in which variation between repli-
cates for a given DGRP strain was >20-fold greater than
the median intrastrain variation (among all our measure-
ments, only triglyceride assays on nine DGRP strains
failed to meet this filter) and subjected all remaining
measurements to genetic analysis as detailed below.
Heritability
Broad-sense heritabilities in Additional file 1: Table S2





using only the DGRP lines for which replicate measure-
ments were carried out. For σ2total for a given trait, we
calculated the variance across all phenotype measure-
ments for all such lines. Separately, for a given DGRP
line we calculated the variance in a given trait across
biological replicates; we then calculated the average of
these variances across lines as our measure of σ2intrastrain.
Genotype filtering
We used DGRP release 2 genotypes and FlyBase R5 co-
ordinates for gene annotations [17, 93]. For the genome-
wide scan of low-frequency variants, we used all DGRP
polymorphic positions with minor allele frequency ≥5 %
(1,932,643 total). For analysis of human disease ortho-
logs, we subjected the set of FlyBase genes with human
homologs [44] to a homolog search via DIOPT-DIST
[94, 95] to find best-match human-Drosophila homologs,
and then filtered for human genes with entries in the
Online Mendelian Inheritance in Man database [42]. All
DGRP polymorphisms with minor allele frequency ≥5 %
(172,637 total) within 1 kb of a homologous gene model
were used in these OMIM homolog association tests.
We did not filter variants based on the coding status of
the polymorphic locus. For the genome-wide scan of
common variants, we used all DGRP markers with
minor allele frequency ≥25 % (734,670 total).
Single-trait association tests
For a given trait and marker, we used the complete co-
hort of average phenotype measurements across all rep-
licates, from flies of all DGRP lines reared on both diets,
as input into an association test via ordinary least
squares regression using the statsmodels module in
Python [96]. The linear model was phenotype = β1 x
genotype + β2 x diet + β3 x genotype x diet + intercept.
Nominal p-values denoted as “genotype” in Table 1 re-
port the probability that β1 = 0, and those denoted as
“interaction” report the probability that β3 = 0. To avoid
the potential for false positives at a given nominal cutoff
owing to p-value inflation, we calculated false discovery
rates via permutation as follows: for a given permutation
i, we randomized phenotype values across DGRP lines,
retaining the true diet assignment, and on this permuted
data set we carried out single-trait association tests for
each marker in turn as above. We counted the number
of markers ni that scored above a given p-value thresh-
old t. We tabulated the false discovery rate at t as the
ratio between the average ni across ten permutations
and the number of markers called at t in the real data.
Cross-phenotype association tests
We carried out cross-phenotype association tests for
starvation resistance and body mass; starvation resist-
ance and triglyceride levels; and starvation resistance
and glucose levels as follows. We used the phenotype
measurements for a given trait pair from flies of all
DGRP lines reared on a given diet, and genotype at a
given marker, as input into the R package SMAT [41].
False discovery rate estimates were calculated via permu-
tation as above. Because triglyceride and glucose level
measurements were each normalized by body mass for a
given DGRP line, these phenotypes were not independent
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and therefore we did not subject any pair among them to
cross-phenotype association testing.
Because our cross-phenotype association analysis in-
volved testing over multiple trait pairs (Additional file 1:
Table S4), we assessed the empirical false discovery rate
(FDR) across the entire set of tests at a given nominal
SMAT p-value threshold t as follows. We tabulated the
number of loci ntrue with SMAT significance at or ex-
ceeding t in at least one trait pair. Next, a permuted as-
signment of genotype to strain was used as input into a
SMAT calculation for each trait pair in turn, yielding the
number of loci nperm with SMAT significance at or
exceeding t in at least one trait pair for this permuta-
tion. We took the ratio between the average of nperm,
across 10 permutations, and ntrue as the multiple
testing-corrected FDR across trait pairs. At t = 1.27E-
08, corresponding to the SMAT p-value attained in
the real data for our least significant SMAT hit, rdgA
(Table 1), this procedure resulted in an estimated
FDR of 12 %. Therefore our SMAT hits have in the
worst case a 12 % multiple-testing corrected FDR. In
the best case, the top scoring polymorphism in
schlank returned p = 4.44E-16, a level that has a 2 %
multiple-testing corrected FDR.
Percent variance explained by mapped loci
For a given trait, we calculated the proportion of the
variance across DGRP lines explained by a given mapped
locus as the R2 from the model phenotype = β1 x geno-
type + intercept, fit via regression as above using mea-
surements from all lines on both diets. The results serve
as an upper bound on the proportion of variance ex-
plained, due to the Beavis effect [97, 98]. For a given
locus mapped in cross-phenotype association tests, we
carried out regression and calculated R2 as above for
each of the two traits, and in Table 1 the greater of the
two is reported.
Functional genomic analysis
We tested for enrichment of association signal among
gene ontology (GO) biological processes as follows.
Given the results from a single-trait or cross-phenotype
association scan across markers as above, we first tabu-
lated the single best-scoring marker for every gene
tested. We then used the ranked list of these genes as
input into GOglm, which tests for GO term enrich-
ment in a ranked list without arbitrary thresholding
into significant and insignificant genes, and corrects
for gene length effects [37]. Only GO terms with >10
members with association results were considered for
analysis. The resulting enrichment significance esti-
mates were corrected for multiple testing with the
Benjamini-Hochberg method. Annotation was from
GOseq [99].
Gene knockdown by RNAi
For a given candidate gene, we used functional valid-
ation strategies that enable the study of a line in which
the gene is perturbed as a comparison with an isogenic
control of the same background. For this purpose, for
each gene we acquired a strain harboring a UAS-driven
RNAi construct [100] from VDRC [101], or from the
TRiP resource at the Bloomington Drosophila Stock
Center [92], and we also acquired lines expressing a con-
stitutive GAL4 driver [102] or an RU486-inducible Gen-
eSwitch (GS) GAL4-human progesterone receptor
fusion protein driver [103]. Strains used are listed in
Additional file 1: Table S6. Drivers were checked for ac-
tivity by mating to UAS-GFP transgene and assaying for
GFP fluorescence in the progeny. For each knockdown
experiment, five males of the UAS-RNAi line of interest
were crossed to 20 virgin females of a GAL4 line. As
negative controls for the latter, five males lacking the
RNAi construct (background-matched to the RNAi
lines) were crossed to 20 females of the same GAL4 line.
In the case of rdgA we compared a previously character-
ized transposon insertion mutant [61] to a background-
matched control. For each experiment, non-virgin
female progeny were collected as day-old adults and
phenotyped as described below.
qRT-PCR analysis of RNAi target expression
To confirm RNAi-mediated knockdown in a given line
in Additional file 1: Figure S2, total RNA was extracted
from three frozen whole flies per condition via Zymo
Quick RNA MiniPrep kit (R1054). For qRT-PCR, we used
Superscript III Platinum SYBR Green One-Step qRT-PCT
kit from Invitrogen (11736-051) and followed the manufac-
turer’s instructions with a Stratagene Mx3000P qPCR
machine. We used a six point standard curve for each tar-
get gene to calibrate the relative abundance levels of the
amplified mRNA in three technical replicate samples per
condition. ROX dye was used to normalize for reaction
volume loading.
Phenotyping of knockdown and mutant strains
We used knockdown and mutant strains to test candi-
date genes’ roles in body mass, starvation resistance and
lifespan. Genotypes of control and experimental strains
are listed in Additional file 1: Table S6. For body mass
and starvation experiments using GS drivers, at day 1 of
adulthood, flies were sorted onto food containing either
the GS inducer RU486, or ethanol as a control, and body
mass or starvation was assayed 10 days later as for the
DGRP strains (see above). To measure body mass, co-
horts of 15 flies reared on a given diet were frozen and
weighed at day 7 after eclosion for htt and CG43921,
and day 14 for schlank and rdgA. For body mass, signifi-
cance in a given diet was tested by t-test, and interaction
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between the genetic perturbation and diet was tested by
ANOVA. Starvation resistance assays were performed as
on DGRP strains (see above); each trace in main and
supplementary figures reports a representative experi-
ment from among 2–5 biological replicates of 100 non-
virgin female flies per condition. Lifespan assays used
200 non-virgin female flies per condition, 25 flies per
vial, changing media every 2 days. For lifespan assays all
knockdowns were induced only in adult flies. Each trace
in Additional file 1: Figure S5 reports a representative
experiment from among 1–5 biological replicates of
100–200 flies per condition. Survival curves for starva-
tion resistance and lifespan were analyzed with the Cox
proportional hazards method implemented in the R
package “survival”.
Additional file
Additional file 1: Table S1. Correlation between phenotypes in DGRP
lines raised on two different diets. Table S2. Broad-sense heritabilities of
metabolic traits. Table S3. GO terms enriched for association signal in
scans of variants with allele frequency ≥5 %. Table S4. Phenotype pairs
tested via SMAT. Table S5. GO terms enriched for association signal in
scans of variants with allele frequency ≥25 %. Table S6. Strains and
crosses used. Figure S1. Variation in metabolic traits and nutrient response
across the DGRP. In a given bar chart, each bar reports the mean of the
indicated phenotype in an isogenic population of one DGRP line reared
on the indicated diet. Strains are ordered along the x-axis by AL diet
phenotype. The right hand panels report the same data formatted as a
scatterplot. (A), Resistance to acute starvation after rearing adults for 10 days
on the indicated diet. (B), Body mass. (C), Whole body triglyceride (TG)
content, normalized by body mass. (D), Whole body glucose content,
normalized by body mass. a.u., dimensionless arbitrary units. AL, ad libitum
diet; DR, dietary restriction. Figure S2. Decreased expression of schlank, htt,
hwt, and rdgA upon RNAi. In the first, second, fourth, and sixth panels, each
bar reports qRT-PCR measurements of expression of the indicated gene, in a
line reared on the indicated diet and harboring both the GeneSwitch (GS)
activator and a construct for RNAi of the indicated gene under the control
of the indicated driver (da, daughterless; elav, embryonic lethal, abnormal
vision), treated with the GS inducer RU486 (+) or a vehicle control (-); in a
given diet, each expression measurement is normalized to that from the
respective control-treated animals. In the third and fifth panels, each bar
reports qRT-PCR measurements of expression of the indicated gene in a
strain expressing an RNAi construct for the indicated gene regulated by
GAL4 under the daughterless promoter (RNAi) or a background-matched
control (Ctrl) with no RNAi construct; in a given diet, each expression
measurement is normalized to that from the respective control animals.
Figure S3. The GeneSwitch inducer RU486 has no effect on starvation
resistance or body mass. (A), Each trace reports survival of flies expressing
daughterless promoter (da)-driven GAL4-Gene Switch (GS) that do not
harbor an RNAi construct, with drug treatment (dotted lines) or ethanol
vehicle treatment (solid lines) starting from eclosion (n = 2 biological
replicates of 100 flies per condition). (B), Each column reports the
distribution of body mass per fly of the no-RNAi control strain harboring the
da-GS driver, with genotypes and treatments as in (A) (n = 2 populations of
15 flies per condition). The checkered boxes indicate addition of the
RU486 inducer drug. Top, middle, and bottom horizontal bars of a
given vertical box denote the respective quartiles across batches and
technical replicates, and the top and bottom short horizontal bars
report minimum and maximum, respectively. No changes here were
significant by t-test at alpha = 0.05. AL, ad libitum diet; DR, dietary
restriction. For strain details see Additional file 1: Table S6. Figure S4.
The GeneSwitch inducer RU486 has no effect on triglyceride levels in
the absence of an RNAi construct, and htt and hwt knockdown does
not detectably impact triglycerides. (A), Each bar reports whole-body
triglyceride levels in a strain expressing a ubiquitous da-GeneSwitch
driver and no RNAi transgene, treated with the GeneSwitch inducer
RU486 (“+ drug”) or with ethanol alone (“- drug”). (B) and (C), Each bar
reports whole-body triglyceride levels in a strain expressing constitutive
da-GAL4 either with an RNAi construct for the indicated gene (“RNAi”)
or without any RNAi construct for the indicated gene (“control”) (n = 1
population of 15 flies per condition). For strain details see Additional
file 1: Table S6. AL, animals reared on the ad libitum diet; DR, dietary
restriction. Horizontal lines in each boxplot indicate quartiles across
technical replicates, and the top and bottom short horizontal bars
report minimum and maximum, respectively. No changes here were
significant by t-test at alpha = 0.05. Figure S5. Lifespan effects of
schlank, htt, hwt and rdgA knockdown. In each panel, the right-hand
plot reports survival of flies harboring an RNAi construct for one gene
regulated by Act5C-driven GAL4-GeneSwitch treated with the GeneSwitch
inducer RU486 (“+ drug”) or with ethanol alone (“no drug”), and the left-
hand plot is for a background-matched control without an RNAi transgene.
Drug or vehicle treatment was started at eclosion. (A), schlank RNAi. (B),
htt RNAi. (C), hwt RNAi. (D), rdgA RNAi. AL, ad libitum diet; DR, dietary
restriction. *, p < 0.05, **, p < 0.01, ***, p < 10-3, ****, p <10-7, *****, p < 10-15.
Red asterisks denote significance of the effect of the genetic perturbation in
animals reared on AL food, blue denotes significance in animals on DR food,
and purple denotes significance of the interaction between diet and genetic
perturbation. For strain details see Additional file 1: Table S6. Figure S6. hwt
knockdown modestly affects resistance to acute starvation. Each trace re-
ports survival, under acute starvation, of flies harboring a GAL4 regulator
under a daughterless promoter and either a GAL4-regulated RNAi construct
for hwt (dotted lines) or a matched control without a transgene (solid line).
AL, animals reared before starvation treatment on the ad libitum diet; DR,
dietary restriction. For strain details see Additional file 1: Table S6. *, p < 0.05,
**, p < 0.01. (DOCX 2 mb)
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